Respiratory Infection Monitoring
Advanced, Bio-Integrated, and Cloud-Enabled Sensors for Early Diagnosis of Respiratory Infections in the Home Setting
1 other identifier
observational
42
1 country
1
Brief Summary
This study will monitor physical bio-markers such as heart rate, respiratory rate, and temperature to detect potential respiratory infections.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 30, 2020
CompletedStudy Start
First participant enrolled
April 24, 2020
CompletedFirst Posted
Study publicly available on registry
April 27, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 6, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 6, 2022
CompletedFebruary 16, 2023
February 1, 2023
2.4 years
March 30, 2020
February 15, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Efficacy of wearable device to detect respiratory infection parameters: cough count
Device data measuring cough count. Captured by analysis of peak acclerometer graphing and duration in meters per second squared (m/s2).
1 year
Monitoring of respiratory infection symptoms, WURSS-11 Survey
WURSS-11 survey. https://www.fammed.wisc.edu/files/webfm-uploads/documents/research/wurss-11.pdf The WURSS-11 survey will be conducted on a weekly basis by study subjects for the duration of the study (up to 52 weeks).
1 year
Study Arms (1)
Adults
Adults 18 years or older
Eligibility Criteria
Adults
You may qualify if:
- ≥18 years old
- Outpatient at start of the study
- Established clinical history of COPD
- Previous hospital or ICU admission for pneumonia or COPD
- Active corticosteroid prescription
- Willingness to participate in the study (long term continuous wear of the device)
- Ability to apply and remove devices and use a mobile application
You may not qualify if:
- Mental or neurodegenerative disease
- Including a current diagnosis of asthma, respiratory disorders (e.g. active tuberculosis, lung cancer, sarcoidosis, lung fibrosis, pulmonary hypertension, interstitial lung diseases); pneumonia or other RTIs not resolved ≤14 days or ≤7 days, respectively, prior to screening
- Skin condition or wound on suprasternal notch.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwestern Universitylead
- Department of Health and Human Servicescollaborator
Study Sites (1)
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shuai Xu
Northwestern University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 30, 2020
First Posted
April 27, 2020
Study Start
April 24, 2020
Primary Completion
September 6, 2022
Study Completion
September 6, 2022
Last Updated
February 16, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share